Mayo Clinic researchers use AI, biomarkers to personalize rheumatoid arthritis treatment

ROCHESTER, Minn. ― Treatment options for rheumatoid arthritis have often relied on trial and error. Now Mayo Clinic researchers are exploring the use of artificial intelligence (AI) and pharmacogenomics to predict how patients will respond to treatments, and to personalize care. Findings were published in Arthriti s Care& Research. The study focused on predicting the response to methotrexate, one of the most common rheumatoid arthritis medications.   Applying patient data that included genomic, clinical and demographic…
Source: News from Mayo Clinic - Category: Databases & Libraries Source Type: news